Publications
Specialty
Search
Wound Care
05/20/2024
The nitric oxide technology platform is moving forward in Europe and the US with plans to file the regulatory approvals during the course of 6 to 12 months. It anticipates introducing the nitric oxide technology platform in the 2025/26 time frame. CTEC Jan – Apr Earnings Call Transcript
Wound Care
05/20/2024
Urgo has positioned UrgoClean Ag as a tool to be used between sharp debridements in the US. This differs from the European positioning, which doesn’t involve sharp debridement. The variation in positioning is primarily driven by the US payment model. SmartTRAK at SAWC Spring 2024
Wound Care
05/20/2024
Convatec noted that there are 2 prospective clinical studies underway in the US for InnovaMatrix on DFU and VLU treatment, which should be completed and published by year end, along with 2 Real World Evidence studies. CTEC Jan-Apr Earnings Release
Wound Care
05/20/2024
DeRoyal launched its light-deactivated disposable incisional NPWT product at SAWC. The kit comes with 2 dressings that can be used with or without being attached to the NPWT device, which is designed to last 7 days and provide a negative pressure of 80mmHG. SAWC Spring 2024
First Report Managed Care
05/20/2024
Guest expert and AMCP 2024 session presenter Joseph Honcz, RPh, MBA, explores the current role of AI in managed care, barriers to implementation, and strategies for collaborating with managed care leadership to advance the testing of AI technologies.
Wound Care
05/20/2024
A new FAWC grant program launches a 12-month wound care fellowship for physicians. The grants will offer a maximum of $50K to support wound care fellowships nationwide. By investing in physicians, the program holds the potential to revolutionize patient wound care across the US.
Journal of Invasive Cardiology, CardioVascular
05/20/2024
Dr Sergey Gurevich shares background and insights on his paper, "Virtual Reality to Predict Paravalvular Leak in Severe Bicuspid Aortic Valve Stenosis in Transcatheter Aortic Valve Implants."
Oncology
05/20/2024
Shubin Shahab, MD, PhD, discusses how to treat a patient with pediatric pilocytic astrocytoma with a KIAA1549:BRAF fusion.
Oncology
05/20/2024
According to a phase 2 study, brentuximab vedotin combined with dacarbazine or nivolumab demonstrate safety and durable efficacy as a promising treatment alternative for older patients with classical HL unfit for initial conventional chemotherapy.
Oncology
05/20/2024
According to results from a multi-institutional real-world study, teclistamab yielded rapid achievement of deep hematologic response among heavily pre-treated patients with relapsed/refractory multiple myeloma.
Journal of Clinical Pathways
05/20/2024
Shaalan Beg, MD, MBA, FASCO, describes some of the recent advancements in the treatment of chronic lymphocytic leukemia (CLL).
Journal of Invasive Cardiology, CardioVascular
05/20/2024
An 85-year-old man with a history of myocardial infarction and coronary bypass surgery presented with severe symptomatic aortic stenosis.
Neurology, Psych Congress Network, Psychiatry & Behavioral Health
05/20/2024
The severity of obstructive sleep apnea (OSA) events during REM sleep is associated with worse verbal memory impairment in older adults at risk for Alzheimer disease (AD), according to a study published online in the journal Alzheimer’s Research & Therapy.
EMSWorld, Emergency & Mobile Medicine
05/20/2024
Jeanine Newton-Riner provides clarity and guidance around getting yourself fully prepared to offer quality MIH-CP services to your community.
Journal of Invasive Cardiology, CardioVascular
05/20/2024
Video Supplement to "Successful Valve-in-Valve Replacement Using Intravascular Lithotripsy for Femoral Access in an Elderly Patient With Critical Aortic Stenosis and Extensive Vascular Calcification" (Clinical Image).
Journal of Invasive Cardiology, CardioVascular
05/20/2024
An 87-year-old man with a history of heart failure and a modified bio-Bentall Mitroflow 23-mm bioprosthesis (Sorin) was referred to our institution for critical aortic stenosis, which was confirmed by transesophageal echocardiography.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
05/20/2024
The results: Across all pulmonary hypertension groups, average pulmonary arterial pressure decreased with greater lifetime duration of menses. Use of HRT was associated with lower mean pulmonary artery pressure and higher right ventricular fractional shortening and right ventricular ejection fraction.
EMSWorld, Emergency & Mobile Medicine
05/20/2024
Fifty fortunate recipients will receive complete conference registration and $500 gift cards to attend EMS World Expo in Las Vegas this September.
Integrated Healthcare Executive
05/20/2024
In a letter voicing support for the extension of the hospital-at-home (H@H) program through 2027, the American Hospital Association (AHA) went on to suggest a permanent version of the initiative. The H@H model allows eligible patients to receive high-quality care at home rather than staying 3 days or longer in the hospital.
EP Lab Digest
05/20/2024
LAGUNA HILLS, Calif. -- Adagio Medical, Inc. (“Adagio Medical”, “Adagio” or the “Company”), a leading innovator in catheter ablation technologies for ventricular tachycardia (“VT”) and atrial fibrillation (“AF”), today announced the completion of the first commercial procedures using its recently CE-Marked VT Cryoablation System and the U.S. Food and Drug Administration (“FDA”) approval of the FULCRUM-VT Pivotal IDE study of the VT Cryoablation System.